Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild Cognitive Impairment Due to Alzheimer's Disease”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Looking for participantsNCT07724132
What this trial is testing

An Evaluation of Treatments for Sustained Clinical Response (18 Months) in Symptomatic Alzheimer's Disease

Who this might be right for
Alzheimer's Disease (AD)Mild Cognitive Impairment Due to Alzheimer's DiseaseAlzheimer Disease Dementia
University College, London 1,200
Not applicableLooking for participantsNCT07089303
What this trial is testing

Alzheimer's Disease Multinuclear Imaging Neuro-Enhanced Resolution (AD-MINER)

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment Due to Alzheimer's Disease
Chinese PLA General Hospital 750
Not applicableLooking for participantsNCT06618807
What this trial is testing

Infrared Light for Memory Loss in Mild Cognitive Impairment (MCI)

Who this might be right for
Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease
Unity Health Toronto 60
Not applicableLooking for participantsNCT06792877
What this trial is testing

Mindfulness for Cognition in Early-stage Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild Cognitive Impairment (MCI) Due to Alzheimer's DiseaseTBI (Traumatic Brain Injury)+3 more
VA Boston Healthcare System 100
Testing effectiveness (Phase 2)Looking for participantsNCT07027072
What this trial is testing

Study to Evaluate the Efficacy and Safety of KDS2010 in Patients With Alzheimer's Disease With Mild Cognitive Impairment and Mild Dementia Due to Alzheimer's Disease

Who this might be right for
Mild Cognitive Impairment (MCI)Mild DementiaAlzheimer's Disease
NeuroBiogen Co., Ltd 114